Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Roivant Sciences (ROIV) Interest & Investment Income (2021 - 2025)

Roivant Sciences (ROIV) has disclosed Interest & Investment Income for 5 consecutive years, with $43.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest & Investment Income fell 30.05% year-over-year to $43.3 million, compared with a TTM value of $198.8 million through Dec 2025, down 15.67%, and an annual FY2025 reading of $258.4 million, up 76.46% over the prior year.
  • Interest & Investment Income was $43.3 million for Q4 2025 at Roivant Sciences, down from $45.3 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $72.1 million in Q2 2024 and bottomed at $199000.0 in Q4 2021.
  • Average Interest & Investment Income over 5 years is $32.4 million, with a median of $32.0 million recorded in 2023.
  • The sharpest move saw Interest & Investment Income surged 5050.25% in 2022, then plummeted 35.02% in 2025.
  • Year by year, Interest & Investment Income stood at $199000.0 in 2021, then soared by 5050.25% to $10.2 million in 2022, then surged by 211.77% to $32.0 million in 2023, then surged by 93.57% to $61.9 million in 2024, then plummeted by 30.05% to $43.3 million in 2025.
  • Business Quant data shows Interest & Investment Income for ROIV at $43.3 million in Q4 2025, $45.3 million in Q3 2025, and $48.3 million in Q2 2025.